Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06906029 | Abdominal aBscess Catheter Sclerotherapy (ABCS) | PHASE1 | NOT YET_RECRUITING | 60 | — | — | Jul 1, 2026 | Jul 1, 2028 | Jul 11, 2025 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| Iodine Arm | ACTIVE_COMPARATOR | Catheter-based drainage and povidone iodine sclerotherapy of non-fistulous intraabdominal abscesses. |
| Ethanol Arm | ACTIVE_COMPARATOR | Catheter-based drainage and ethanol sclerotherapy of non-fistulous intraabdominal abscesses. |
| Name | Type | Description |
|---|---|---|
| Catheter Sclerotherapy | DRUG | Place a drainage catheter of minimum 14F in caliber and obtain an antimicrobial sample. Saline lavage will be performed by irrigating the abscess and aspirating the contents until the character of the instilled and aspirated fluid are similar. Following this step the cavity will be drained in full and a volume of approximately equal to the cavity of povidone iodine or ethanol will be instilled through the catheter with the catheter turned off to drainage. After approximately two minutes the drain will be opened to gravity and two minutes of additional time will be allotted to drain any excess povidone iodine or ethanol. The catheter will then be removed, and the site dressed with gauze and film dressing. The patient will then be followed clinically in the hospital for at least 48 hours and by phone check in for 7 days. |
Inclusion Criteria: * Male or female, aged over 18years * Cross-sectional imaging (CT, US, MRI) showing an intraabdominal abscess measuring at last 3cm in each dimension without fistula to the bowel or skin. * Provision of signed and dated informed consent form * Stated willingness to comply with a...